These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17047202)

  • 21. Excess risk of colon cancer associated with a polymorphism of the APC gene?
    White RL
    Cancer Res; 1998 Sep; 58(18):4038-9. PubMed ID: 9751604
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Forrest WF; Cavet G
    Science; 2007 Sep; 317(5844):1500; author reply 1500. PubMed ID: 17872427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical advances in treatment options and diagnostics: new tools in the management of breast cancer and colon cancer.
    Hyams DM
    Manag Care; 2010 Oct; 19(10 Suppl 4):3-11. PubMed ID: 21128521
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter.
    Cruickshanks HA; Tufarelli C
    Genomics; 2009 Dec; 94(6):397-406. PubMed ID: 19720139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The bewildering complexity of cancer].
    Jordan B
    Med Sci (Paris); 2011; 27(8-9):781-6. PubMed ID: 21880268
    [No Abstract]   [Full Text] [Related]  

  • 27. c-K-ras mutations in human carcinomas occur preferentially in codon 12.
    Yanez L; Groffen J; Valenzuela DM
    Oncogene; 1987; 1(3):315-8. PubMed ID: 3330777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Banding analysis of three primary cancers.
    Kovács G
    Acta Cytol; 1978; 22(6):538-41. PubMed ID: 282753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas.
    Jeong EG; Soung YH; Lee JW; Lee SH; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2006 Dec; 119(12):2986-7. PubMed ID: 16998794
    [No Abstract]   [Full Text] [Related]  

  • 30. Hereditary cancers: from discovery to intervention.
    Knudson AG
    J Natl Cancer Inst Monogr; 1995; (17):5-7. PubMed ID: 8573454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational research on hereditary colon, breast, and ovarian cancers.
    Li FP
    J Natl Cancer Inst Monogr; 1995; (17):1-4. PubMed ID: 8573439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.
    Sierko E; Wojtukiewicz MZ; Zimnoch L; Kisiel W
    Thromb Haemost; 2010 Jan; 103(1):198-204. PubMed ID: 20062932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of EP300 in colon, breast and ovarian carcinomas.
    Bryan EJ; Jokubaitis VJ; Chamberlain NL; Baxter SW; Dawson E; Choong DY; Campbell IG
    Int J Cancer; 2002 Nov; 102(2):137-41. PubMed ID: 12385008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-genetical analysis of colonic cancer. I. Occurrence, frequency in families and segregation analysis].
    Belev NF; Gar'kavtseva RF; Samotyia EE; Trubnikov VI; Gindilis VM
    Genetika; 1986 Sep; 22(9):2347-54. PubMed ID: 3770477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p.
    Ribieras S; Song-Wang XG; Martin V; Lointier P; Frappart L; Dante R
    J Cell Biochem; 1994 Sep; 56(1):86-96. PubMed ID: 7806594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregation of colon cancer in family data.
    Bale SJ; Chakravarti A; Strong LC
    Genet Epidemiol; 1984; 1(1):53-61. PubMed ID: 6544232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
    Bianco C; Strizzi L; Mancino M; Rehman A; Hamada S; Watanabe K; De Luca A; Jones B; Balogh G; Russo J; Mailo D; Palaia R; D'Aiuto G; Botti G; Perrone F; Salomon DS; Normanno N
    Clin Cancer Res; 2006 Sep; 12(17):5158-64. PubMed ID: 16951234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
    Baehner FL; Lee M; Demeure MJ; Bussey KJ; Kiefer JA; Barrett MT
    J Surg Oncol; 2011 May; 103(6):563-73. PubMed ID: 21480251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.